Genetic modification of an islet tumor cell line inhibits its rejection.
Georgiou
H M
HM
Walter & Eliza Hall Institute for Medical Research, Victoria, Australia.
Brady
J L
JL
Silva
A
A
Lew
A M
AM
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000096:biosynthesis*; D060908:CTLA-4 Antigen; D002461:Cell Line, Transformed; D017690:Cell Transplantation; D006084:Graft Rejection / Q000517:prevention & control*; D018796:Immunoconjugates; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007340:Insulinoma / Q000378:metabolism / Q000473:pathology*; D008156:Luciferases / Q000096:biosynthesis; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D009368:Neoplasm Transplantation; D010190:Pancreatic Neoplasms / Q000378:metabolism / Q000473:pathology*; D011994:Recombinant Proteins / Q000096:biosynthesis; D013539:Simian virus 40; D014162:Transfection; D014185:Transplantation, Isogeneic; D014916:Whole-Body Irradiation
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D007328:Insulin; D011994:Recombinant Proteins; D000069594:Abatacept; D008156:Luciferases